Literature DB >> 31909536

Hypoxia-induced HE4 in tubular epithelial cells promotes extracellular matrix accumulation and renal fibrosis via NF-κB.

Lei Zhang1,2, Limin Liu1,3, Ming Bai1,4, Minna Liu1,4, Lei Wei1,4, Zhen Yang1,4, Qi Qian5, Xiaoxuan Ning4,6, Shiren Sun1,4.   

Abstract

Hypoxia-induced extracellular matrix (ECM) deposition is an important cause of renal fibrosis that is triggered by unknown mechanisms. Human epididymis secretory protein 4 (HE4) is a newly discovered key molecule that causes ECM deposition. We used the unilateral ureteral obstruction (UUO) mouse model to investigate the expression and mechanisms of HE4 in the pathogenesis of renal fibrosis. Results were confirmed in the HK2 cell line and in human donors of kidney tissue with chronic kidney disease. Hypoxia significantly increased HE4 in renal tubular epithelial cells. HE4 overexpression activated the NF-κB pathway through the NF-κB transcription-activating group P65 by phosphorylation and nuclear translocation. NF-κB upregulated tissue inhibitor metalloproteinases 1, which may inhibit ECM degradation through inhibition of matrix metallopeptidase 2 activity. Silencing HE4 inhibited hypoxia-induced ECM deposition and alleviated fibrosis in UUO mice in vivo and blocked NF-κB activation in vitro. Expression of HE4 in the tubulointerstitium was positively correlated with tubulointerstitial fibrosis in tissue samples from patients with chronic kidney disease. Our results suggest that hypoxia induces renal fibrosis by upregulating HE4 and activating the HIF-1α/HE4/NF-κB signaling pathway. Uncovering the molecular mechanisms and function of HE4 overexpression in hypoxia-induced renal fibrosis will provide important insights into understanding renal fibrosis and antifibrotic strategies.
© 2019 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  NF-κB; chronic hypoxia; extracellular matrix; human epididymis secretory protein 4; renal fibrosis

Year:  2019        PMID: 31909536     DOI: 10.1096/fj.201901950R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  17 in total

1.  Proteins Associated with Risk of Kidney Function Decline in the General Population.

Authors:  Morgan E Grams; Aditya Surapaneni; Jingsha Chen; Linda Zhou; Zhi Yu; Diptavo Dutta; Paul A Welling; Nilanjan Chatterjee; Jingning Zhang; Dan E Arking; Teresa K Chen; Casey M Rebholz; Bing Yu; Pascal Schlosser; Eugene P Rhee; Christie M Ballantyne; Eric Boerwinkle; Pamela L Lutsey; Thomas Mosley; Harold I Feldman; Ruth F Dubin; Peter Ganz; Hongzhe Lee; Zihe Zheng; Josef Coresh
Journal:  J Am Soc Nephrol       Date:  2021-09       Impact factor: 14.978

2.  Elevated serum human epididymis protein 4 is associated with disease severity and worse survival in idiopathic pulmonary fibrosis: a cohort study.

Authors:  Mi Tian; Kaifang Meng; Yujuan Gao; Ji Zhang; Miaomiao Xie; Yaqiong Tian; Xiaoqin Liu; Miao Ma; Ying Cai; Hongyan Wu; Jingjing Ding; Jingyu Chen; Hourong Cai
Journal:  Ann Transl Med       Date:  2022-09

3.  Roles of SIRT6 in kidney disease: a novel therapeutic target.

Authors:  Xueyan Yang; Jun Feng; Wei Liang; Zijing Zhu; Zhaowei Chen; Jijia Hu; Dingping Yang; Guohua Ding
Journal:  Cell Mol Life Sci       Date:  2021-12-24       Impact factor: 9.261

4.  Dapagliflozin Attenuates Contrast-induced Acute Kidney Injury by Regulating the HIF-1α/HE4/NF-κB Pathway.

Authors:  Xu Huang; Xiaoxu Guo; Gaoliang Yan; Yang Zhang; Yuyu Yao; Yong Qiao; Dong Wang; Gecai Chen; Weiwei Zhang; Chengchun Tang; Feng Cao
Journal:  J Cardiovasc Pharmacol       Date:  2022-06-01       Impact factor: 3.271

5.  Human epididymis protein 4 aggravates airway inflammation and remodeling in chronic obstructive pulmonary disease.

Authors:  Yuan Zhan; Jinkun Chen; Jixing Wu; Yiya Gu; Qian Huang; Zhesong Deng; Shanshan Chen; Xiaojie Wu; Yongman Lv; Zhilin Zeng; Jungang Xie
Journal:  Respir Res       Date:  2022-05-12

6.  Integrative Informatics Analysis of Transcriptome and Identification of Interacted Genes in the Glomeruli and Tubules in CKD.

Authors:  Lingyun Liu; Fuzhe Ma; Yuanyuan Hao; Zhengzi Yi; Xiaoxia Yu; Bo Xu; Chengguo Wei; Jinghai Hu
Journal:  Front Med (Lausanne)       Date:  2021-02-12

7.  Clinical significance of serum human epididymis protein 4 in liver fibrosis: An experimental study.

Authors:  Yulei Hou; Fengzeng Li; Juanjuan Chen; Jinqiu Zhao; Detao Li; Hui Chen
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

8.  Long non-coding RNA RP11-465L10.10 promotes vascular smooth muscle cells phenotype switching and MMP9 expression via the NF-κB pathway.

Authors:  Yang Lin; Haoyue Huang; You Yu; Lianbo Shao; Zhenya Shen; Feng Zhu; Weizhang Xiao; Ziying Yang
Journal:  Ann Transl Med       Date:  2021-12

9.  Fer exacerbates renal fibrosis and can be targeted by miR-29c-3p.

Authors:  Chen-Min Sun; Wen-Yi Zhang; Shu-Yan Wang; Gang Qian; Dong-Liang Pei; Guang-Ming Zhang
Journal:  Open Med (Wars)       Date:  2021-09-13

Review 10.  G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases.

Authors:  Nan Li; Shan Shan; Xiu-Qin Li; Ting-Ting Chen; Meng Qi; Sheng-Nan Zhang; Zi-Ying Wang; Ling-Ling Zhang; Wei Wei; Wu-Yi Sun
Journal:  Front Immunol       Date:  2022-01-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.